Cancer and biochemical research

BACKGROUND: The proto-oncogene bcl-2 encodes a protein that inhibits programmed cell death (apoptosis). The protein is expressed in basal cells in normal human epithelium, but no data are available on the frequency or clinical importance of its expression in carcinoma. We studied bcl-2 expression in patients with non-…

• IŞINSU KUZU

Özet henüz yok.

• AYLİN YÜCEL

In this study, removal of some heavy metals ions (Mn2+, Fe2+, Ni2+ and Cu2+) from aqueous solution by adsorption was investigated. For this purpose, high-grade MnSO4.H2O, FeSO4.7H2O, NiSO4.7H2O and CuSO4.5H2O were used as heavy metal samples. The commercial activated carbon (Merck 2514), chitosan and agar were used as…

Peroxidases (EC 1.11.1.7; donor: hydrogen peroxide oxidoreductase) are part of a large group of enzymes. In this study, peroxidase, a primer antioxidant enzyme, was purified with 19.3 fold and 0.2% efficiency from cauliflower (Brassica oleracea L.) by ammonium sulphate precipitation, dialysis, CM-Sephadex ion-exchange…

• EKREM KÖKSAL

Peroxidases (EC 1.11.1.7; donor: hydrogen peroxide oxidoreductase) are part of a large group of enzymes. In this study, peroxidase, a primer antioxidant enzyme, was purified with 19.3 fold and 0.2% efficiency from cauliflower (Brassica oleracea L.) by ammonium sulphate precipitation, dialysis, CM-Sephadex ion-exchange…

• İLHAMİ GÜLÇİN

BACKGROUND: One of the major goals of oncology is to predict the response of patients with cancer to chemotherapeutic agents by employing laboratory methods variously called 'tumor chemosensitivity assays', 'drug response assays', or 'drug sensitivity assays', in vitro. The MTT assay is one of the methods used to pred…

• ENGİN ULUKAYA

BACKGROUND: One of the major goals of oncology is to predict the response of patients with cancer to chemotherapeutic agents by employing laboratory methods variously called 'tumor chemosensitivity assays', 'drug response assays', or 'drug sensitivity assays', in vitro. The MTT assay is one of the methods used to pred…

• MUKADDES ÇOLAKOĞULLARI

Özet henüz yok.

• DERYA GÜMÜRDÜLÜ

Özet henüz yok.

BACKGROUND: High dose chemotherapy with autologous stem cell transplantation is currently the treatment of choice for relapsed or refractory lymphoma patients. However, its applicability is mostly restricted to patients responding to salvage chemotherapy. Optimal salvage regimen for these patients is unclear. In this…

• NURİYE ÖZDEMİR
• YÜKSEL ÜRÜN

Özet henüz yok.

• İLHAMİ ÇELİK

Özet henüz yok.

• DENİZ KÖKSAL